{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:06:46Z","timestamp":1780668406451,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41409-026-02855-8","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:05:45Z","timestamp":1776117945000},"page":"718-725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomes"],"prefix":"10.1038","volume":"61","author":[{"given":"Ming-Hao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Nan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0267-1081","authenticated-orcid":false,"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-9034","authenticated-orcid":false,"given":"Yi-Fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9881-7945","authenticated-orcid":false,"given":"Xiao-Dong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-2231","authenticated-orcid":false,"given":"Yu-Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1253-7465","authenticated-orcid":false,"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0245-6792","authenticated-orcid":false,"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5018-6507","authenticated-orcid":false,"given":"Zheng-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"2855_CR1","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0140-6736(05)66515-4","volume":"365","author":"RA Brodsky","year":"2005","unstructured":"Brodsky RA, Jones RJ. Aplastic anaemia. Lancet. 2005;365:1647\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(05)66515-4.","journal-title":"Lancet"},{"key":"2855_CR2","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/bloodadvances.2018021162","volume":"2","author":"GE Georges","year":"2018","unstructured":"Georges GE, Doney K, Storb R. Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. Blood Adv. 2018;2:2020\u201328. https:\/\/doi.org\/10.1182\/bloodadvances.2018021162.","journal-title":"Blood Adv"},{"key":"2855_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41409-020-01169-7","volume":"56","author":"ZL Xu","year":"2021","unstructured":"Xu ZL, Huang XJ. Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges. Bone Marrow Transpl. 2021;56:779\u201385. https:\/\/doi.org\/10.1038\/s41409-020-01169-7.","journal-title":"Bone Marrow Transpl"},{"key":"2855_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217594","volume":"621","author":"ZL Xu","year":"2025","unstructured":"Xu ZL, Zhang YP, Ye BD, Zhao X, Zhou M, Lu PH, et al. Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40-50: a CBMTR registry-based propensity score matching analysis over the last decade. Cancer Lett. 2025;621:217594. https:\/\/doi.org\/10.1016\/j.canlet.2025.217594.","journal-title":"Cancer Lett"},{"key":"2855_CR5","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/s41409-020-0897-2","volume":"55","author":"G ElGohary","year":"2020","unstructured":"ElGohary G, El Fakih R, de Latour R, Risitano A, Marsh J, Schrezenmeier H, et al. Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT). Bone Marrow Transpl. 2020;55:1906\u201317. https:\/\/doi.org\/10.1038\/s41409-020-0897-2.","journal-title":"Bone Marrow Transpl"},{"key":"2855_CR6","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00277-023-05339-7","volume":"102","author":"J Zhao","year":"2023","unstructured":"Zhao J, Ma L, Zheng M, Su L, Guo X. Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia. Ann Hematol. 2023;102:2565\u201387. https:\/\/doi.org\/10.1007\/s00277-023-05339-7.","journal-title":"Ann Hematol"},{"key":"2855_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.837335","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Huo J, Liu L, Shen Y, Chen J, Zhang T, et al. Comparison of hematopoietic stem cell transplantation outcomes using matched sibling donors, haploidentical donors, and immunosuppressive therapy for patients with acquired aplastic anemia. Front Immunol. 2022;13:837335. https:\/\/doi.org\/10.3389\/fimmu.2022.837335.","journal-title":"Front Immunol"},{"key":"2855_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","volume":"124","author":"G Socie","year":"2014","unstructured":"Socie G, Ritz J. Current issues in chronic graft-versus-host disease. Blood. 2014;124:374\u201384. https:\/\/doi.org\/10.1182\/blood-2014-01-514752.","journal-title":"Blood"},{"key":"2855_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev.me.35.020184.000303","volume":"35","author":"HJ Deeg","year":"1984","unstructured":"Deeg HJ, Storb R. Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med. 1984;35:11\u201324. https:\/\/doi.org\/10.1146\/annurev.me.35.020184.000303.","journal-title":"Annu Rev Med"},{"key":"2855_CR10","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","volume":"4","author":"AE DeZern","year":"2020","unstructured":"DeZern AE, Zahurak ML, Symons HJ, Cooke KR, Rosner GL, Gladstone DE, et al. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide. Blood Adv. 2020;4:1770\u201379. https:\/\/doi.org\/10.1182\/bloodadvances.2020001729.","journal-title":"Blood Adv"},{"key":"2855_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-019-0775-9","volume":"12","author":"LP Xu","year":"2019","unstructured":"Xu LP, Wang SQ, Ma YR, Gao SJ, Cheng YF, Zhang YY, et al. Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study. J Hematol Oncol. 2019;12:87 https:\/\/doi.org\/10.1186\/s13045-019-0775-9.","journal-title":"J Hematol Oncol"},{"key":"2855_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41409-019-0773-0","volume":"55","author":"PH Prata","year":"2020","unstructured":"Prata PH, Eikema DJ, Afansyev B, Bosman P, Smiers F, Diez-Martin JL, et al. Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party. Bone Marrow Transpl. 2020;55:1050\u201358. https:\/\/doi.org\/10.1038\/s41409-019-0773-0.","journal-title":"Bone Marrow Transpl"},{"key":"2855_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.889784","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chen X, Li L, Li Y, Lin L, Cao Y, et al. Retrospective comparison of efficacy and safety of rabbit anti-thymocyte globulin and porcine anti-lymphocyte globulin in patients with acquired aplastic anemia undergoing hematopoietic stem cell transplantation from matched sibling donors. Front Immunol. 2022;13:889784. https:\/\/doi.org\/10.3389\/fimmu.2022.889784.","journal-title":"Front Immunol"},{"key":"2855_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.scib.2022.01.024","volume":"67","author":"LP Xu","year":"2022","unstructured":"Xu LP, Xu ZL, Wang SQ, Wu DP, Gao SJ, Yang JM, et al. Long-term follow-up of haploidentical transplantation in relapsed\/refractory severe aplastic anemia: a multicenter prospective study. Sci Bull. 2022;67:963\u201370. https:\/\/doi.org\/10.1016\/j.scib.2022.01.024.","journal-title":"Sci Bull"},{"key":"2855_CR15","doi-asserted-by":"publisher","first-page":"470.e1","DOI":"10.1016\/j.jtct.2023.04.004","volume":"29","author":"J Yu","year":"2023","unstructured":"Yu J, Khera N, Turnbull J, Stewart SK, Williams P, Bhatt V, et al. Impact of chronic graft-versus-host disease on patient employment, income, and informal caregiver burden: findings from the living with chronic GVHD patient survey. Transpl Cell Ther. 2023;29:470.e1\u2013470.e9. https:\/\/doi.org\/10.1016\/j.jtct.2023.04.004.","journal-title":"Transpl Cell Ther"},{"key":"2855_CR16","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","volume":"105","author":"RE Curtis","year":"2005","unstructured":"Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA, Flowers ME, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005;105:3802\u201311. https:\/\/doi.org\/10.1182\/blood-2004-09-3411.","journal-title":"Blood"},{"key":"2855_CR17","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transpl. 1995;15:825\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"2855_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transpl. 2015;21:389\u2013401.e1. https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.001.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2855_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3760\/cma.j.cn121090-20240611-00217","volume":"45","author":"Hematopoietic Stem Cell Application Group CSoHCMA","year":"2024","unstructured":"Hematopoietic Stem Cell Application Group CSoHCMA. Chinese expert consensus on the diagnosis and treatment of chronic graft-versus-host disease (2024). Zhonghua Xue Ye Xue Za Zhi. 2024;45:713\u201326. https:\/\/doi.org\/10.3760\/cma.j.cn121090-20240611-00217.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"2855_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/mpr.124","volume":"11","author":"LR Schultz","year":"2002","unstructured":"Schultz LR, Peterson EL, Breslau N. Graphing survival curve estimates for time-dependent covariates. Int J Methods Psychiatr Res. 2002;11:68\u201374. https:\/\/doi.org\/10.1002\/mpr.124.","journal-title":"Int J Methods Psychiatr Res"},{"key":"2855_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2478\/jtim-2018-0028","volume":"6","author":"C Liu","year":"2018","unstructured":"Liu C, Shao Z. Aplastic Anemia in China. J Transl Int Med. 2018;6:134\u20137. https:\/\/doi.org\/10.2478\/jtim-2018-0028.","journal-title":"J Transl Int Med"},{"key":"2855_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3324\/haematol.12020","volume":"93","author":"E Montane","year":"2008","unstructured":"Montane E, Ibanez L, Vidal X, Ballarin E, Puig R, Garcia N, et al. Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica. 2008;93:518\u201323. https:\/\/doi.org\/10.3324\/haematol.12020.","journal-title":"Haematologica"},{"key":"2855_CR23","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41409-024-02419-8","volume":"59","author":"LP Xu","year":"2024","unstructured":"Xu LP, Lu PH, Wu DP, Huang H, Jiang EL, Liu DH, et al. Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transpl. 2024;59:1726\u201334. https:\/\/doi.org\/10.1038\/s41409-024-02419-8.","journal-title":"Bone Marrow Transpl"},{"key":"2855_CR24","first-page":"151","volume":"4","author":"D Niederwieser","year":"1989","unstructured":"Niederwieser D, Pepe M, Storb R, Witherspoon R, Longton G, Sullivan K. Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia. Bone Marrow Transpl. 1989;4:151\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"2855_CR25","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1182\/bloodadvances.2022009505","volume":"7","author":"S Herzog","year":"2023","unstructured":"Herzog S, Weisdorf DJ, Shanley R, Rayes A, Holtan SG, Young JA, et al. Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes. Blood Adv. 2023;7:3644\u201350. https:\/\/doi.org\/10.1182\/bloodadvances.2022009505.","journal-title":"Blood Adv"},{"key":"2855_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11684-019-0702-z","volume":"13","author":"M Lv","year":"2019","unstructured":"Lv M, Zhang X, Xu L, Wang Y, Yan C, Chen H, et al. Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia. Front Med. 2019;13:667\u201379. https:\/\/doi.org\/10.1007\/s11684-019-0702-z.","journal-title":"Front Med"},{"key":"2855_CR27","doi-asserted-by":"publisher","unstructured":"Olivieri A, Mancini G. Current approaches for the prevention and treatment of acute and chronic GVHD. Cells. 2024;13. https:\/\/doi.org\/10.3390\/cells13181524.","DOI":"10.3390\/cells13181524"},{"key":"2855_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbmt.2017.11.004","volume":"24","author":"M Qayed","year":"2018","unstructured":"Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, et al. Influence of age on acute and chronic GVHD in children undergoing HLA-identical sibling bone marrow transplantation for acute leukemia: implications for prophylaxis. Biol Blood Marrow Transpl. 2018;24:521\u20138. https:\/\/doi.org\/10.1016\/j.bbmt.2017.11.004.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2855_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571884","volume":"11","author":"GDE Cuvelier","year":"2020","unstructured":"Cuvelier GDE, Li A, Drissler S, Kariminia A, Abdossamadi S, Rozmus J, et al. Age-related differences in the biology of chronic graft-versus-host disease after hematopoietic stem cell transplantation. Front Immunol. 2020;11:571884. https:\/\/doi.org\/10.3389\/fimmu.2020.571884.","journal-title":"Front Immunol"},{"key":"2855_CR30","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1007\/s00277-024-05800-1","volume":"103","author":"Y Nakamura","year":"2024","unstructured":"Nakamura Y, Zaimoku Y, Yamaguchi H, Yamazaki H, Kanaya M, Uchida N, et al. Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia. Ann Hematol. 2024;103:3121\u201333. https:\/\/doi.org\/10.1007\/s00277-024-05800-1.","journal-title":"Ann Hematol"},{"key":"2855_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-018-1127-2","volume":"35","author":"G Afram","year":"2018","unstructured":"Afram G, Simon JAP, Remberger M, Caballero-Vel\u00e1zquez T, Martino R, Pinana JL, et al. Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting. Med Oncol. 2018;35:79. https:\/\/doi.org\/10.1007\/s12032-018-1127-2.","journal-title":"Med Oncol"},{"key":"2855_CR32","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/bmt.2015.51","volume":"50","author":"CK Brierley","year":"2015","unstructured":"Brierley CK, Littlewood TJ, Peniket AJ, Gregg R, Ward J, Clark A, et al. Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT. Bone Marrow Transpl. 2015;50:931\u20138. https:\/\/doi.org\/10.1038\/bmt.2015.51.","journal-title":"Bone Marrow Transpl"},{"key":"2855_CR33","doi-asserted-by":"publisher","first-page":"e0282753","DOI":"10.1371\/journal.pone.0282753","volume":"18","author":"I Novitzky-Basso","year":"2023","unstructured":"Novitzky-Basso I, Schain F, Batyrbekova N, Webb T, Remberger M, Keating A, et al. Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease. PLoS ONE. 2023;18:e0282753. https:\/\/doi.org\/10.1371\/journal.pone.0282753.","journal-title":"PLoS ONE"},{"key":"2855_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/bmt.2015.195","volume":"51","author":"C Fiuza-Luces","year":"2016","unstructured":"Fiuza-Luces C, Simpson RJ, Ramirez M, Lucia A, Berger NA. Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients. Bone Marrow Transpl. 2016;51:13\u201326. https:\/\/doi.org\/10.1038\/bmt.2015.195.","journal-title":"Bone Marrow Transpl"},{"key":"2855_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.714033","volume":"11","author":"M Lei","year":"2021","unstructured":"Lei M, Li X, Zhang Y, Qu Q, Jiao W, Zhou H, et al. Comparable outcomes and health-related quality of life for severe aplastic anemia: haploidentical combined with a single cord blood unit vs matched related transplants. Front Oncol. 2021;11:714033. https:\/\/doi.org\/10.3389\/fonc.2021.714033.","journal-title":"Front Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02855-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02855-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02855-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:08:00Z","timestamp":1780664880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02855-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2855"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-02855-8","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}